MeSH term
Frequency | Condition_Probility | Animals | 38 | 0.0 |
Humans | 111 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Cell Cycle Proteins/metabolism | 6 | 1.0 |
Cell Line | 23 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Mice | 19 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Protein Binding | 16 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 41 | 0.0 |
S-Phase Kinase-Associated Proteins/metabolism | 4 | 57.0 |
Signal Transduction/physiology | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Ubiquitin/*metabolism | 7 | 3.0 |
Ubiquitin-Protein Ligases/genetics/*metabolism | 2 | 10.0 |
Cell Cycle/physiology | 10 | 3.0 |
Cell Cycle Proteins/*genetics | 2 | 1.0 |
Cell Division/drug effects | 6 | 0.0 |
Gene Amplification | 5 | 0.0 |
Gene Expression | 5 | 0.0 |
In Situ Hybridization, Fluorescence | 5 | 0.0 |
Lung Neoplasms/*genetics/pathology | 2 | 2.0 |
Oligoribonucleotides, Antisense/pharmacology | 2 | 20.0 |
Research Support, Non-U.S. Gov't | 74 | 0.0 |
S-Phase Kinase-Associated Proteins | 45 | 64.0 |
Cell Division/genetics | 2 | 0.0 |
Female | 24 | 0.0 |
Male | 24 | 0.0 |
Middle Aged | 22 | 0.0 |
Prognosis | 14 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 4 | 0.0 |
Transfection | 15 | 0.0 |
Tumor Cells, Cultured | 19 | 0.0 |
Cell Cycle Proteins/*metabolism | 17 | 5.0 |
Cell Line, Tumor | 15 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Hela Cells | 15 | 0.0 |
Phosphorylation | 22 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Tumor Suppressor Proteins/*metabolism | 15 | 15.0 |
3T3 Cells | 3 | 0.0 |
Cell Cycle Proteins/chemistry/*metabolism | 2 | 7.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Fatty Acids, Unsaturated/pharmacology | 2 | 3.0 |
G1 Phase | 8 | 2.0 |
Hydrolysis | 2 | 0.0 |
Cell Cycle/drug effects/physiology | 3 | 5.0 |
Cysteine Endopeptidases/metabolism | 9 | 3.0 |
Enzyme Inhibitors/metabolism | 2 | 0.0 |
Genes, Tumor Suppressor | 6 | 0.0 |
Multienzyme Complexes/antagonists & inhibitors/metabolism | 2 | 9.0 |
Phosphoric Monoester Hydrolases/*metabolism | 3 | 3.0 |
Proteasome Endopeptidase Complex | 17 | 3.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Adult | 15 | 0.0 |
Aged | 20 | 0.0 |
Aged, 80 and over | 13 | 0.0 |
Disease Progression | 3 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Neoplasm Staging | 5 | 0.0 |
S-Phase Kinase-Associated Proteins/*metabolism | 8 | 88.0 |
Survival Rate | 4 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
Cell Cycle | 13 | 1.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
Proteins/metabolism | 3 | 0.0 |
Rats | 10 | 0.0 |
Up-Regulation | 3 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Time Factors | 11 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Ubiquitin/metabolism | 14 | 6.0 |
Cell Cycle/drug effects | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Immunohistochemistry | 20 | 0.0 |
*Tumor Suppressor Proteins | 11 | 0.0 |
Cell Cycle/*physiology | 4 | 1.0 |
Ligases/*metabolism | 6 | 6.0 |
S Phase | 8 | 2.0 |
Base Sequence | 7 | 0.0 |
Cell Cycle Proteins/chemistry/genetics/*metabolism | 2 | 7.0 |
*Cullin Proteins | 7 | 10.0 |
Cytoplasm/metabolism | 4 | 0.0 |
Ubiquitin-Protein Ligases | 12 | 5.0 |
Ubiquitins/*metabolism | 7 | 4.0 |
*Cell Cycle Proteins | 6 | 0.0 |
Cell Division/physiology | 6 | 0.0 |
Down-Regulation/physiology | 2 | 2.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Ligases/genetics/*metabolism | 4 | 8.0 |
Microtubule-Associated Proteins/genetics/metabolism | 2 | 10.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Multienzyme Complexes/metabolism | 7 | 3.0 |
Neoplasms/genetics/*metabolism | 2 | 8.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
RNA Interference | 3 | 1.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
S-Phase Kinase-Associated Proteins/genetics/*metabolism | 5 | 100.0 |
Microtubule-Associated Proteins/*metabolism | 5 | 4.0 |
Tumor Suppressor Proteins/genetics/metabolism | 2 | 6.0 |
Cell Cycle Proteins/genetics/*metabolism | 12 | 8.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
Cells, Cultured | 6 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Ki-67 Antigen/analysis | 3 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Culture Media, Serum-Free | 2 | 0.0 |
Cysteine Endopeptidases | 3 | 6.0 |
Cysteine Proteinase Inhibitors/pharmacology | 2 | 0.0 |
Multienzyme Complexes/antagonists & inhibitors | 2 | 7.0 |
Recombinant Fusion Proteins/genetics/*metabolism | 2 | 14.0 |
*CDC2-CDC28 Kinases | 10 | 1.0 |
Cyclin E/metabolism | 2 | 1.0 |
Protein-Serine-Threonine Kinases/metabolism | 6 | 0.0 |
SKP Cullin F-Box Protein Ligases | 2 | 5.0 |
Adolescent | 3 | 0.0 |
Blotting, Western | 7 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
S-Phase Kinase-Associated Proteins/*biosynthesis | 3 | 100.0 |
Treatment Outcome | 3 | 0.0 |
Tumor Suppressor Proteins/metabolism | 5 | 4.0 |
Mutation | 6 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
*Muscle Proteins | 7 | 2.0 |
*Cell Cycle | 4 | 1.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
*Saccharomyces cerevisiae Proteins | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Ubiquitins/metabolism | 4 | 2.0 |
Cyclin A/*metabolism | 3 | 7.0 |
Cyclin-Dependent Kinases/*metabolism | 3 | 1.0 |
Enzyme Activation | 4 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Cyclin-Dependent Kinases/metabolism | 8 | 2.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cyclin A/metabolism | 4 | 5.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors | 4 | 5.0 |
Cyclin-Dependent Kinases/*antagonists & inhibitors | 2 | 1.0 |
Enzyme Inhibitors/*metabolism | 3 | 3.0 |
In Vitro | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Binding Sites | 4 | 0.0 |
DNA, Complementary/analysis | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Cyclins/metabolism | 4 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Cell Cycle Proteins/*biosynthesis/genetics | 3 | 18.0 |
Tumor Suppressor Proteins/*biosynthesis/genetics | 2 | 14.0 |
Cell Differentiation | 3 | 0.0 |
Mitosis | 2 | 0.0 |
Cell Division | 8 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
CDC2-CDC28 Kinases/*metabolism | 3 | 17.0 |
Mice, Nude | 2 | 0.0 |
Tumor Suppressor Proteins/genetics/*metabolism | 4 | 7.0 |
Cell Cycle Proteins/*physiology | 2 | 3.0 |
Down-Regulation | 8 | 0.0 |
S-Phase Kinase-Associated Proteins/*physiology | 2 | 66.0 |
Survival Analysis | 8 | 0.0 |
DNA Primers | 3 | 0.0 |
Gene Expression Regulation, Neoplastic/genetics | 3 | 1.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Retroviridae/genetics | 4 | 1.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
Comparative Study | 6 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Cell Cycle Proteins/*analysis | 5 | 27.0 |
S-Phase Kinase-Associated Proteins/*analysis | 4 | 100.0 |
Tumor Suppressor Proteins/*analysis | 3 | 21.0 |
Case-Control Studies | 2 | 0.0 |
Protein Kinases/genetics/*metabolism | 2 | 2.0 |
RNA, Small Interfering/pharmacology | 2 | 2.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Cell Cycle Proteins/drug effects/metabolism | 2 | 14.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
S-Phase Kinase-Associated Proteins/drug effects/*metabolism | 2 | 100.0 |
G1 Phase/drug effects | 2 | 1.0 |
Ubiquitin/genetics/metabolism | 3 | 42.0 |
Microscopy, Fluorescence | 2 | 0.0 |
NIH 3T3 Cells | 2 | 0.0 |
Cell Cycle Proteins/*biosynthesis | 4 | 9.0 |
Tumor Suppressor Proteins/*biosynthesis | 3 | 12.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors/metabolism | 2 | 3.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors/metabolism | 2 | 2.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Biological Markers/analysis | 3 | 0.0 |
Disease-Free Survival | 3 | 0.0 |
Prostate-Specific Antigen/blood | 2 | 2.0 |
Prostatic Neoplasms/*metabolism | 2 | 1.0 |
Cell Division/*physiology | 2 | 1.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
Down-Regulation/drug effects/physiology | 2 | 5.0 |
G1 Phase/physiology | 2 | 2.0 |
*Apoptosis | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 2 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Eukaryotic Cells/*metabolism | 2 | 4.0 |
Proto-Oncogene Proteins c-myc/genetics/*metabolism | 2 | 4.0 |
S Phase/genetics | 2 | 9.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
RNA, Neoplasm/genetics/metabolism | 2 | 1.0 |
Microfilament Proteins/*metabolism | 2 | 3.0 |
Child | 2 | 0.0 |
Cysteine Endopeptidases/drug effects/metabolism | 2 | 20.0 |
Multienzyme Complexes/drug effects/metabolism | 2 | 28.0 |
Up-Regulation/drug effects/physiology | 2 | 4.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
